Home » Topics » BioWorld Science

BioWorld Science
RSS

Baxter to acquire Immuno AG

Sep. 6, 1996

Cellegy issued patent covering novel drug delivery system

Sep. 6, 1996

Memtec and Gelman Sciences sign merger agreement

Sep. 6, 1996

ImmunoTherapeutics obtains option for drug delivery technology

Sep. 6, 1996

Molecular Simulations and Procept enter research collaboration

Sep. 6, 1996

Renewed collaboration for Ribozyme and Pharmacia Biotech

Sep. 6, 1996

Ontogen and Boehringer Ingelheim sign research agreement

Sep. 6, 1996

NS-2389: a potential new antidepressant

Sep. 6, 1996

Reversible MAO inhibitors from Hoechst Marion Roussel

Sep. 6, 1996

Lilly's olanzapine deemed approvable

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...